Spots Global Cancer Trial Database for Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
Official Title:
Study ID: NCT00036140
Conditions
Interventions
Study Description
Brief Summary: The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Center, Los Angeles, California, United States
Research Center, Los Angeles, California, United States
Research Center, Rancho Mirage, California, United States
Research Center, Cleveland, Ohio, United States
Research Center, Marshfield, Wisconsin, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
